BioCryst Pharmaceuticals | BCRX - Ebit





Ebit Alterar Data
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Chugai Pharma JPY 160.86B 2.09B 2026-06
Daiichi Sankyo JPY 85.1B 4.44B 2026-06
DBV Technologies USD -47.9M 2.85M 2026-03
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Glaxosmithkline GBP 2.31B 14.92M 2026-03
Incyte USD 700.4M 356.23M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Novavax USD 20.94M 100.32M 2025-12
PTC Therapeutics USD 45.89M 127.51M 2026-03
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06